[A case report of an advanced esophageal carcinoma (stage II) without signs of recurrence in 5 years after chemoradiotherapy. With reference to p53 immunohistochemistry as an indicator for prognostic evaluation of chemoradiotherapy]

Nihon Shokakibyo Gakkai Zasshi. 2003 Sep;100(9):1140-2.

[Article in Japanese]

Authors

Keiki Isogai¹, Reine Moriuchi, Isao Tarasawa, Takashi Yabana, Tomohiro Kato, Seiya Nakahara, Rieko Murakami, Akinori Senota, Toshihiro Ban

Affiliation

¹ Department of Internal Medicine, Social Welfare Corporation, Hokkaido Social Work Association, Otaru Hospital.

PMID: 14524242

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Squamous Cell / drug therapy
Carcinoma, Squamous Cell / pathology*
Carcinoma, Squamous Cell / radiotherapy
Cisplatin / administration & dosage
Combined Modality Therapy
Drug Administration Schedule
Esophageal Neoplasms / drug therapy
Esophageal Neoplasms / pathology*
Esophageal Neoplasms / radiotherapy
Fluorouracil / administration & dosage
Humans
Immunohistochemistry
Neoplasm Staging
Prognosis
Radiotherapy Dosage
Tumor Suppressor Protein p53 / analysis*

Substances

Tumor Suppressor Protein p53
Cisplatin
Fluorouracil

Supplementary concepts

CF regimen